In bacteria and eukaryotes, the last two steps of de novo purine biosynthesis are catalyzed by bifunctional purine-biosynthesis protein (PurH), which is composed of two functionally independent domains linked by a flexible region. The N-terminal domain possesses IMP cyclohydrolase activity and the C-terminal domain possesses aminoimidazole-4-carboxamide ribonucleotide transformylase activity. This study reports the expression, purification, crystallization and preliminary X-ray crystallographic analysis of PurH from Escherichia coli with an N-terminal His 6 tag. The crystals diffracted to a maximum resolution of 3.05 Å and belonged to the monoclinic space group P2 1 , with unit-cell parameters a = 76.37, b = 132.15, c = 82.64 Å , = 111.86 .
Introduction
The production of inosine 5 0 -monophosphate (IMP) from smallmolecule precursors in organisms is known as de novo purine biosynthesis (Buchanan & Hartman, 1959) and is composed of ten enzymatic catalytic steps in higher organisms, while an additional enzyme is required for the sixth step in prokaryotes. IMP is then converted to guanosine 5 0 -monophosphate (GMP) or adenosine 5 0 -monophosphate (AMP) by subsequent enzymes. IMP, AMP and GMP are also generated via the purine-salvage pathway, which is the sole pathway for obtaining purine nucleotides in some parasitic organisms (Zhang et al., 2008) . Because of the critical role of purine nucleotides in the synthesis of RNA and DNA, the de novo purinebiosynthetic pathway is considered to be an important target for anticancer, antiviral and antibacterial drug design.
The last two steps in the purine-biosynthetic pathway are the conversion of aminoimidazole-4-carboxamide ribonucleotide (AICAR) to the final product IMP (Fig. 1) . In bacteria and eukaryotes these two steps are catalyzed by the bifunctional enzyme AICAR transformylase (AICAR Tfase)/IMP cyclohydrolase (IMPCH) (EC 2.1.2.3), also known as bifunctional purine-biosynthesis protein (PurH). This enzyme has become a target for the development of anticancer therapeutics, especially for the investigation of specific antifolate reagents (Cheong et al., 2004; Wolan et al., 2003) and nonfolate inhibitors Xu et al., 2004) , which are analogues of cofactor N 10 -formyltetrahydrofolate (10-f-THF) which can completely inhibit AICAR Tfase activity.
Bifunctional purine-biosynthesis protein from Escherichia coli (EcPurH) is encoded by the purH gene. This enzyme is composed of two domains linked by a flexible region. The N-terminal domain possesses IMPCH activity and the C-terminal domain possesses AICAR Tfase activity. Coupling of the two domains has been shown to be essential for the catalytic process, as the AICAR Tfase reaction # 2011 International Union of Crystallography All rights reserved
Figure 1
The reactions catalyzed by PurH (Wall et al., 2000) . favours the reverse direction by itself and the irreversible cyclization of 5-formyl-AICAR (FAICAR) to IMP drives formyl transfer in the forward direction (Xu et al., 2007) .
The structures of several prokaryotic and eukaryotic PurH enzymes have been determined (Axelrod et al., 2008; Cheong et al., 2004; Greasley et al., 2001; Wolan et al., 2002 Wolan et al., , 2003 Xu et al., 2004 Xu et al., , 2007 , which reveal that the relative positions of the two domains in PurH differ in different species. EcPurH has inserted sequences in its N-terminal domain, a deleted sequence in its interdomain region and deleted or inserted sequences in its C-terminal domain compared with the sequences of PurH from other species for which structures have been solved (Fig. 2) . These sequence variations could cause the crystallization communications Multi-sequence alignment of EcPurH with PurH enzymes from other species for which structures have been solved. The inserted sequences in the N-terminal domain, the deleted sequence in the interdomain region and the deleted and inserted sequences in the C-terminal domain of EcPurH are indicated by blue, green and black arrows respectively. The alignment was generated using the ClustalW web server.
interdomain positioning in EcPurH to differ from that in PurH from other species, which could make substrate transfer between the two domains of EcPurH different from that in other PurH enzymes. To explore the spatial relationship of the two catalytic active sites in EcPurH and its impact on its catalytic rate, the expression, purification, crystallization and preliminary X-ray crystallographic analysis of this enzyme are reported in this study.
Materials and methods

Cloning, expression and purification
The cDNA of full-length EcPurH was obtained via PCR from the E. coli strain K12 genome and was cloned into pET28a (Novagen) excised using NdeI and XhoI to create recombinant EcPurH with an N-terminal hexahistidine tag (MGSSHHHHHHLVPRGSH). The sequence of the cDNA was confirmed by DNA sequencing. A single colony of E. coli Rosetta (DE3) (Novagen) bacteria harbouring the expression vector was cultured in 8 ml Luria-Bertani broth overnight and was then used to inoculate 0.8 l medium containing 50 mg ml À1 kanamycin. The cells were grown at 310 K for 2.5 h until the OD 600 nm reached 0.5-0.8 and protein expression was then induced for 24 h with 0.25 mM isopropyl -d-1-thiogalactopyranoside (IPTG) at 289 K. The bacteria were collected and resuspended in 50 ml binding buffer (20 mM Tris-HCl pH 8.0, 500 mM NaCl). After disrupting the cells by sonication, the bacteria were centrifuged at 15 200g for 0.5 h. The clean lysate supernatant was loaded onto Ni-NTA agarose (GE Healthcare) resin pre-equilibrated with binding buffer. The tagged protein was eluted with 30 ml binding buffer containing 500 mM imidazole, which was then concentrated for further purification using Superdex 200 gel-filtration (GE Healthcare) chromatography eluted with binding buffer containing 5 mM dithiothreitol (DTT). The retention volume corresponding to the target protein indicated that it was a monomer in solution. The fractions containing the peak were pooled, exchanged with buffer A (20 mM Tris-HCl pH 8.0, 100 mM NaCl, 5 mM DTT) and then further purified using Q-Sepharose Fast Flow (GE Healthcare) chromatography eluted with a linear gradient of NaCl from 0.1 to 0.5 M. The fractions from the peak corresponding to the target protein ( Fig. 3a) were pooled and concentrated to 56 mg ml À1 using a 10 kDa cutoff Amicon centrifugal ultrafilter concentrator (Millipore). Examination of the purified protein by SDS-PAGE revealed a single band corresponding to the expected molecular weight (Fig. 3b ). The protein concentration was measured using the BCA Protein Assay Kit (Pierce).
Lysine methylation
EcPurH contains a relatively large amount of lysine (28 lysines in 592 residues), which could prevent crystallization. Therefore, lysine methylation was performed basically as described previously (Walter et al., 2006) to improve the quality of crystallization. The purified EcPurH was diluted to less then 1 mg ml À1 in 50 mM HEPES pH 7.5, 250 mM NaCl. 20 ml freshly prepared 1 M dimethylamine-borane complex (ABC; Fluka) and 40 ml 1 M formaldehyde (Fluka) were then added per millilitre of protein solution. The reaction was carried out at 277 K. After 2 h, a further 20 ml 1 M ABC and 40 ml 1 M formaldehyde were added per millilitre of solution and the mixture was incubated for a further 2 h. 10 ml 1 M ABC per millilitre of solution was then added and the mixture was incubated at 277 K overnight. Finally, the reaction solution was concentrated and applied onto a Superdex 200 gel-filtration chromatography column preequilibrated with buffer A in order to remove ABC and formaldehyde.
Crystallization
Preliminary screening for initial crystallization conditions for EcPurH without reductive lysine methylation was performed by the sitting-drop vapour-diffusion method using ProPlex (Molecular Dimensions) at 287 K by mixing 1 ml 56 mg ml À1 protein solution with an equal volume of reservoir solution in 48-well plates. Small block-shaped crystals were obtained from the condition 0.1 M sodium acetate pH 5.0, 1 M ammonium sulfate. The conditions were further optimized using various concentrations of ammonium sulfate versus a pH range of 4.5-5.5. The diffraction quality of the crystals from the optimal conditions (Fig. 4a ) was poor. Microseeding of these crystals did not improve the diffraction quality. Initial crystallization conditions of EcPurH with reductive lysine methylation were screened using the same kit and using the same method as used for EcPurH without reductive lysine methylation. Clusters of plate-shaped crystals ( Fig. 4b ) appeared in the condition 0.8 M sodium/potassium hydrogen phosphate pH 7.5 after one week and reached maximum size after one month; these crystals were used for data collection. 
X-ray diffraction data collection and processing
Before data collection, one piece of the crystal cluster was picked up and quick-soaked in a cryoprotectant solution consisting of 25%(v/v) glycerol, 0.8 M sodium/potassium hydrogen phosphate pH 7.5 and flash-cooled in a nitrogen stream at 100 K. X-ray diffraction data were collected on beamline 17U1 of the Shanghai Synchrotron Radiation Facility (SSRF) using an MX-225 CCD detector (MAR Research). The crystal-to-detector distance was kept at 240 mm and the crystal was rotated through a total of 200 , with 1 rotation and an exposure time of 1.2 s per frame. The crystal diffracted to a maximum resolution of 3.05 Å . All data were indexed and integrated with iMOSFLM (Battye et al., 2011) and scaled using SCALA (Evans, 2006) from the CCP4 suite (Winn et al., 2011) . Analysis of the systematic absences in the diffraction data characterized the space group as P2 1 . The final statistics of data collection and processing are listed in Table 1 .
Results and discussion
Full-length PurH from E. coli strain K12 was expressed and purified to homogeneity with an N-terminal hexahistidine tag. Because of the poor diffraction quality of the crystals of EcPurH, lysine methylation was performed. EcPurH with reductive lysine methylation crystallized from 0.8 M sodium/potassium hydrogen phosphate pH 7.5. The crystals diffracted to a maximum resolution of 3.05 Å and belonged to the monoclinic space group P2 1 , with unit-cell parameters a = 76. 37, b = 132.15, c = 82.64 Å , = 111.86 . The resulting R merge was 14.0% overall and the average mosaicity was 1.02 . The highest probability of three molecules per asymmetric unit suggested a Matthews coefficient of 2.18 Å 3 Da À1 (Matthews, 1968) , with a solvent content calculated as 43.62%.
To accommodate the possible difference in the relative positioning of the two domains of EcPurH compared with homologous structures, structure determination will be attempted via the molecularreplacement method using the structures of the N-terminal domain of PurH from Gallus gallus (PDB entry 1m9n; Wolan et al., 2002) 
